Qingtong Capital

Qingtong Capital is a comprehensive and elite new economy investment bank, founded in 2014, with offices in Beijing, Shanghai, and Shenzhen.
Over the past nine years since its establishment, Qingtong Capital has completed nearly 500 financing transactions, with services covering four major industries: mass consumption, technology, TMT, and healthcare. Representative clients include Lvji Technology [01745], MiaoEye Technology [688003], Titan Technology [688133], Best Inc. [BEST], OatZac, Ubras, Zhihu, HiScene, Deepwise Healthcare, Wanghai Kangxin, Yusai Biology, and others.
Operating as an investment bank with an investor's perspective, Qingtong Capital adheres to boutique services and a professional attitude of continuous improvement, utilizing full industry chain resources and multi-dimensional value-added services to empower startups throughout their entire growth lifecycle.
With outstanding performance, Qingtong Capital has been recognized by the industry, having been selected multiple times for the "Top 10 New-Type Investment Banks in China" by ChinaVenture; "Top 10 Most Influential New-Type Investment Banks in China" by 36Kr; "Top 10 FA Pioneers in China" by TMTPost; "Top 5 Best Investment Banks in China" by Jiemian News; "Top 10 Most Active Financial Advisory Institutions" and "Top 5 Best Financial Advisory Institutions in the Mass Consumption Field" by Qimingpian; "Top 10 Financial Advisory Institutions in China's Hard Technology Field" by Qimingpian; "Top 10 Boutique Investment Banks for China's New Energy Smart Vehicles" by EqualOcean; and "Top 10 Most Active Financial Advisory Institutions of the Year", "Top 10 Most Active Financial Advisory Institutions in the Medical Field", "Top 10 Most Active Financial Advisory Institutions in the Advanced Manufacturing Field", and "Top 10 Most Active Financial Advisory Institutions in the Mass Consumption Field" by XinSheng, among other authoritative rankings.